Most antidepressants are metabolized through the cytochrome P (CYP) 450 pathway; therefore, most drug metabolism genes on pharmacogenetic testing panels are related to CYP450 oxidase enzyme subunits.

Finding an effective antidepressant can be as hit-or-miss as finding a drinkable cappuccino in a strip mall…or a date-able date on Tinder. And we’re not being flip. “Part of the challenge of ...

UCSF is the first California facility and among about 10 in the nation to offer these tests, according to a May 4 news release from the San Francisco-based hospital. With the program, patients will ...

The treatment of clinical depression presents unique challenges, with many patients voicing concerns that echo a disheartening struggle: "I have tried every medication for depression, and nothing ...

Beginning May 9, UC San Francisco will be the first hospital in California, and one of only a few nationwide, to offer pharmacogenetic testing. The test will provide critical clues about a patient's ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient ...

Beginning May 9, UC San Francisco will be the first hospital in California, and one of only a few nationwide, to offer pharmacogenetic testing. The test will provide critical clues about a patient’s ...

The FDA authorized 23andMe to market its pharmacogenetic report Oct. 31, marking the agency’s first time greenlighting a direct-to-consumer DNA test for this purpose. Pharmacogenetics is an area of ...

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was informed on Friday, November 1, 2024, of an updated ...

Genedrive (GB:GDR) has released an update. Genedrive PLC, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 ID Kit and CYP2C19 ID Kit, enhancing personalized ...